The FDA has issued an upgraded recall for millions of baked goods made by FGF Brands due to possible listeria contamination.

Trial showed promising results for patients with IBD and autoimmune liver disease with 80% achieving clinical remission ...

Lawmakers are not fundamentally altering existing federal fentanyl policy; they are simply continuing a framework that has ...

Male health supplements have become increasingly important in today's fast-paced world where nutritional gas and lifestyle ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be short-lived deal ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

A self-described Hollywood producer is facing life in prison after being convicted of murder in the deaths of two women. A ...

Eli Lilly & Co. is tapping the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Recalled products involved a mix of Bavarian doughnuts, French crullers, éclairs and coffee rolls, according to FDA.

The first drug proven to slow down Alzheimer's won't be available to dementia patients in Scotland - unless they pay £60,000 a year to get it privately.